|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02661 QINGSONG HEALTH
Nominal 
() | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 83,791 | 7,834 | 57,201 |
| Net Cash from / (used in) Investing Activities | 16,533 | (4,887) | (94,895) |
| Net Cash from / (used in) Financing Activities | (30,623) | (4,951) | (4,986) |
| Increase / (Decrease) in Cash & Cash Equivalents | 69,701 | (2,004) | (42,680) |
| Cash & Cash Equivalents at beginning of period | 293,220 | 295,609 | 337,650 |
| Effect of Foreign Exchange Rate Changes | (343) | (385) | 639 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 362,578 | 293,220 | 295,609 |
| Remarks: | Real time quote last updated: 18/12/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 86,045 |
| %Change | 437.916% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |